Who Needs VCs? Steven Quay's Atossa Genetics, Inc. Seeks $15M IPO For Breast Cancer Test
Published: May 21, 2010
Xconomy -- Most biotech firms toil as obscure private companies for years to prove their ideas work in the clinic. They have to hustle non-stop for venture capital to keep the doors open just long enough to someday cash out with an IPO.